Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
AbbVie
Sort By
Newest First
1 / 3
1 / 3
Collaboration
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
Anima Biotech Inc.
PR-M01-23-01-166
Jan 10, 2023
Regulatory Compliance
Addressing Regulatory Challenges for Ophthalmic Combination Products
Jeff Tremain; Ania VanDyke
AbbVie Contract Manufacturing
PAO-04-022-CL-09
Apr 28, 2022
Aseptic Processing
Unique Manufacturing Challenges Associated with Sterile Eye Ointments
Tim Schuetter
AbbVie Contract Manufacturing
PAO-04-022-CL-04
Apr 19, 2022
Hot Melt Extrusion
Streamline HME Projects with Early Partner Engagement
Jared A. Baird, Ph.D.; Ania VanDyke
AbbVie Contract Manufacturing
PAO-08-21-CL-06
Aug 27, 2021
Drug Update
AbbVie Provides Update Regarding RINVOQ® (upadacitinib) for the Treatment of Moderate to Severe Atopic Dermatitis in the U.S.
AbbVie
PR-M07-21-011
Jul 22, 2021
M&A
AbbVie Exercises Right to Acquire TeneoOne and Lead Asset TNB-383B for the Potential Treatment of Relapsed or Refractory Multiple Myeloma
AbbVie
PR-M07-21-01
Jul 06, 2021
Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio
AbbVie
PR-M05-21-008-993
May 12, 2021
Croatia
Healthcare in Croatia
AbbVie Contract Manufacturing
PAO-04-22-R221-59
Apr 29, 2021
Lyophilization
Shorten Time to Market with New Data-Driven Lyophilization Process
Jeff Tremain
AbbVie Contract Manufacturing
PAO-03-21-CL-07
Mar 29, 2021
Partnership
AbbVie and I-Mab Enter Into Global Strategic Partnership for Differentiated Immuno-oncology Therapy
AbbVie
PR-M09-20-NI-06
Sep 04, 2020
M&A
AbbVie and Allergan Receive Clearance from U.S. Federal Trade Commission for AbbVie's Acquisition of Allergan
AbbVie
PR-M05-20-NI-012-1566
May 08, 2020
Business
AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisition
AbbVie
PR-M01-20-NI-016
Jan 09, 2020
Collaboration
AbbVie and Scripps Research Announce Collaboration to Develop a Broad Range of New Therapeutics
AbbVie
PR-M12-19-NI-021
Dec 12, 2019
M&A
AbbVie Issues Large Bond to Finance Allergan Merger
Nice Insight
PAO-M11-19-NI-006
Nov 12, 2019
FDA Approval
AbbVie Receives FDA Approval of RINVOQ™ (upadacitinib), an Oral JAK Inhibitor For The Treatment of Moderate to Severe Rheumatoid Arthritis
AbbVie
PR-M08-19-NI-073
Aug 26, 2019
M&A
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
AbbVie
PR-M07-19-NI-038
Jul 16, 2019
M&A
AbbVie to Acquire Allergan for $63 Billion
AbbVie
PR-M06-19-NI-052
Jun 25, 2019
ADC
Speeding up ADC Development With the Right Partner Organization
Courtney Morgret, Ph.D.
AbbVie Contract Manufacturing
PAP-Q2-2019-CL-001
May 24, 2019
FDA Approval
FDA Approves Venetoclax for CLL and SLL
U.S. Food & Drug Administration
PR-M05-19-NI-057
May 20, 2019
Announcement
AbbVie Provides Update on Depatuxizumab Mafodotin (Depatux-M), an Investigational Medicine for Newly Diagnosed Glioblastoma, an Aggressive Form of Brain Cancer
AbbVie
PR-M05-19-NI-054
May 20, 2019